A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney Function

This trial is intended to understand how the body processes repinatrabit in people with moderate liver impairment and severe kidney impairment and also to compare these results with people of similar age, weight, and sex who have normal liver function.

NCT Number	NCT07713758
Lead Sponsor	Otsuka Pharmaceutical Development & Commercialization, Inc.
Conditions	Phenylketonuria
Enrollment	32 participants
Start Date	2026-07-17
Primary Completion	2027-02-09 (estimated)
Study Completion	2027-02-15 (estimated)
Updated on ClinicalTrials.gov	2026-08-12